Bo F. Hansen
Bagsvaerd, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models.
Journal: Diabetologia
Published: July 08, 2022
Author Correction: Molecular engineering of safe and efficacious oral basal insulin.
Journal: Nature communications
Published: July 10, 2021
Increased insulin receptor binding and increased IGF-1 receptor binding are linked with increased growth of L6hIR cell xenografts in vivo.
Journal: Scientific reports
Published: January 17, 2020
Molecular engineering of safe and efficacious oral basal insulin.
Journal: Nature communications
Published: December 13, 2019
Intraintestinal and Parenteral Administration of an Insulin Analogue Leads to Comparable Activation of Signaling Downstream of the Insulin Receptor in the Small Intestine.
Journal: Journal of diabetes science and technology
Published: June 14, 2019
Cross-species reactive monoclonal antibodies against the extracellular domains of the insulin receptor and IGF1 receptor.
Journal: Journal of immunological methods
Published: August 03, 2018
A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.
Journal: Carcinogenesis
Published: November 19, 2014
Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues.
Journal: Journal of applied toxicology : JAT
Published: July 29, 2014
Last Updated: 09/26/2026